Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • The Seven Bridges CGC: Boon for Bioinformatics, Success for a Startup

    Jul 20, 2016, 04:55 AM by Michael Croft
    Bio-IT World It's been a busy two years for Seven Bridges. In May 2014, Seven Bridges was introducing its open source cancer informatics pipeline: open source algorithms running on the proprietary Seven Bridges cloud infrastructure. Less than six months later, the company was awarded one of three National Cancer Institute Cloud Pilot contracts.
    Full story
  • Indivumed and Definiens Partner to Unlock the Power of Tumor Tissue for Drug Discovery and Development

    Jul 19, 2016, 10:02 AM by Michael Croft
    MUNICH, GERMANY - Jul 19, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization and Indivumed, GmbH, based in Hamburg, Germany announced today a strategic partnership to offer a unique combination of tissue-based biomarker validation and assay development with Definiens Cognition Network Technology® for image analysis and data mining
    Full story
  • NewLeaf Symbiotics Appoints VP for Research and Discovery

    Jul 19, 2016, 09:20 AM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Jul 19, 2016 - NewLeaf Symbiotics, announced today the appointment of Dr. Janne Kerovuo as Vice President for Research and Discovery
    Full story
  • Systems Toxicology Computational Challenge Results Announced

    Jul 18, 2016, 13:45 PM by Michael Croft
    Bio-IT World | The Systems Toxicology Computational Challenge results have been announced from the fourth challenge launched by sbv IMPROVER, an international scientific crowdsourcing initiative.
    Full story
  • Appistry’s Vision for Clinical Lab Analysis

    Jul 15, 2016, 05:50 AM by Michael Croft
    Bio-IT World | Appistry launches managed services for clinical sequencing, incorporating GenomePilot, and covering the entire pipeline from when data comes off the sequencers to results analysis.
    Full story
  • With new owner the hated impact factor is overdue for change

    Jul 14, 2016, 09:47 AM by Michael Croft
    STAT | The impact factor is a poor measure of a journal's quality, and academics say it should either be overhauled or done away with entirely.
    Full story
  • Wellcome Trust launches open-access publishing venture

    Jul 13, 2016, 08:16 AM by Michael Croft
    Nature News & Comment | Wellcome Open Research is meant to allow Wellcome grant recipients to publish their findings more quickly. The charity hopes other funders will follow a similar model. Management of the venture will be contracted to F1000Research.
    Full story
  • Genomic Medicine Training, New Storage Options, Food Allergy Science

    Jul 12, 2016, 15:10 PM by Michael Croft
    Bio-IT World | News and product launches from around the Bio-IT landscape include a postdoctoral fellowship in genomics medicine in Alabama, a synthetic biology partnership, new Lustre storage, and the Broad's food allergy science institute.
    Full story
  • A Drug For Postpartum Depression? Sage Passes Early Test With Experimental Treatment

    Jul 12, 2016, 14:48 PM by Michael Croft
    Forbes | Encouraging news is out today for the treatment of severe postpartum depression. Sage Therapeutics, a biotech company in Cambridge, Mass., reported that its experimental drug was able to relieve severe symptoms of postpartum depression for 70% of patients within a few days, and keep them in remission for a month.
    Full story
  • Danforth Plant Science Center and Valent BioSciences will Collaborate in Unique Root Science Initiative

    Jul 12, 2016, 13:07 PM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Jul 12, 2016 - Valent BioSciences Corporation (VBC) and the Donald Danforth Plant Science Center today announced the finalization of a multi-year, Master Cooperation Agreement in the area of root science and the rhizosphere
    Full story
  • Crop Roots Enact Austerity Measures During Drought to Bank Water

    Jul 11, 2016, 17:29 PM by Michael Croft
    ST. LOUIS, UNITED STATES - Jul 11, 2016 - With a growing world population and a changing climate, understanding how agriculturally important plants respond to drought is crucial
    Full story
  • Intel's Cancer Cloud: Complementing NCI Collaboration

    Jul 11, 2016, 13:25 PM by Michael Croft
    Bio-IT World | Intel may have missed out on a major government grant, but that hasn't stopped it from developing a collaborative cloud for genomicists and bioinformaticians that it wanted to build all along.
    Full story
  • IT spending will shrink worldwide due to Brexit Gartner predicts

    Jul 8, 2016, 08:47 AM by Michael Croft
    Computerworld | Britain's vote to exit the European Union will depress global IT spending, according to Gartner analyst John-David Lovelock.
    Full story
  • Juno Therapeutics Stops Trial Of Cancer-Killing Cells After 3 Patient Deaths

    Jul 8, 2016, 08:38 AM by Michael Croft
    Forbes | Three patients have died in a closely watched study of using genetically engineered white blood cells to treat adult leukemia patients, forcing the trial to be put on hold. The news is a blow for Juno Therapeutics, the biotechnology startup valued at $4.3 billion.
    Full story
  • Siemens Investment Accelerates Launch of Riffyn’s Ground-breaking R&D Design Software

    Jul 8, 2016, 07:37 AM by Michael Croft
    OAKLAND, CA, UNITED STATES - Jul 8, 2016 - Riffyn, Inc. announces an investment by Siemens Venture Capital to accelerate the launch of its cloud-based research process design software
    Full story
  • Obama Seeks To Make Mark On Genetic Medicine

    Jul 7, 2016, 11:05 AM by Michael Croft
    Forbes | After a few weeks of hype around the Obama administration's efforts to speed cancer research, officials tonight announced plans to kickstart efforts around the president's Precision Medicine Initiative.
    Full story
  • Cloud Adoption Numbers Are All Over the Map

    Jul 7, 2016, 10:07 AM by Michael Croft
    Fortune | Johnson & Johnson turned off its last mainframe and plans to move 85% of its software to the cloud. Is it mainstream or an outlier?
    Full story
  • Recipharm appoints new General Manager in Research Triangle Park, USA

    Jul 7, 2016, 07:34 AM by Michael Croft
    RESEARCH TRIANGLE PARK, NC - Jul 7, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has appointed Ann Flodin as General Manager of its wholly owned new subsidiary Recipharm Laboratories Inc
    Full story
  • Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M

    Jul 6, 2016, 13:02 PM by Michael Croft
    Xconomy | Bind Therapeutics and its treatment for treatment for non-small cell lung cancer may soon be owned by one-time partner Pfizer. Bind, which filed for Chapter 11 bankruptcy in May asked the court to approve a bid from Pfizer on July 1.
    Full story
  • Non-profit Research Accelerator SAVE JON Relaunches as Curable

    Jul 6, 2016, 09:43 AM by Michael Croft
    PITTSBURGH, PA - Jul 6, 2016 - SAVE JON, a non-profit research accelerator that applies engineering approaches to medicine, today announced that it is relaunching as Curable
    Full story
  • «
  • 331
  • 332
  • 333
  • 334
  • 335
  • 336
  • 337
  • 338 (current)
  • 339
  • 340
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy